Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
mBio. 2023 Feb 28;14(1):e0228022. doi: 10.1128/mbio.02280-22. Epub 2022 Dec 12.
Human metapneumovirus (HMPV) is one of the leading causes of respiratory illness (RI), primarily in infants. Worldwide, two genetic lineages (A and B) of HMPV are circulating that are antigenically distinct and can each be further divided into genetic sublineages. Surveillance combined with large-scale whole-genome sequencing studies of HMPV are scarce but would help to identify viral evolutionary dynamics. Here, we analyzed 130 whole HMPV genome sequences obtained from samples collected from individuals hospitalized with RI and partial fusion ( = 144) and attachment ( = 123) protein gene sequences obtained from samples collected from patients with RI visiting general practitioners between 2005 and 2021 in the Netherlands. Phylogenetic analyses demonstrated that HMPV continued to group in the four sublineages described in 2004 (A1, A2, B1, and B2). However, one sublineage (A1) was no longer detected in the Netherlands after 2006, while the others continued to evolve. No differences were observed in dominant (sub)lineages between samples obtained from patients with RI being hospitalized and those consulting general practitioners. In both populations, viruses of lineage A2 carrying a 180-nucleotide or 111-nucleotide duplication in the attachment protein gene became the most frequently detected genotypes. In the past, different names for the newly energing lineages have been proposed, demonstrating the need for a consistent naming convention. Here, criteria are proposed for the designation of new genetic lineages to aid in moving toward a systematic HMPV classification. Human metapneumovirus (HMPV) is one of the major causative agents of human respiratory tract infections. Monitoring of virus evolution could aid toward the development of new antiviral treatments or vaccine designs. Here, we studied HMPV evolution between 2005 and 2021, with viruses obtained from samples collected from hospitalized individuals and patients with respiratory infections consulting general practitioners. Phylogenetic analyses demonstrated that HMPV continued to group in the four previously described sublineages (A1, A2, B1, and B2). However, one sublineage (A1) was no longer detected after 2006, while the others continued to evolve. No differences were observed in dominant (sub)lineages between patients being hospitalized and those consulting general practitioners. In both populations, viruses of lineage A2 carrying a 180-nucleotide or 111-nucleotide duplication in the attachment protein gene became the most frequently detected genotypes. These data were used to propose criteria for the designation of new genetic lineages to aid toward a systematic HMPV classification.
人偏肺病毒(HMPV)是导致呼吸道疾病(RI)的主要原因之一,主要发生在婴儿中。在全球范围内,有两种遗传谱系(A 和 B)的 HMPV 在传播,它们具有不同的抗原性,并且每个谱系都可以进一步分为遗传亚谱系。对 HMPV 的监测以及大规模全基因组测序研究很少见,但这有助于确定病毒的进化动态。在这里,我们分析了 2005 年至 2021 年间从因 RI 住院的个体采集的 130 个完整 HMPV 基因组序列和从因 RI 就诊的普通科医生处采集的部分融合( = 144)和附着( = 123)蛋白基因序列,这些个体采集的样本来自荷兰的患者。系统发生分析表明,HMPV 继续分为 2004 年描述的四个亚谱系(A1、A2、B1 和 B2)。然而,亚谱系 A1 自 2006 年后在荷兰不再被检测到,而其他亚谱系继续进化。在因 RI 住院和就诊的患者的样本中,优势(亚)谱系没有观察到差异。在两个人群中,附着蛋白基因中带有 180 个核苷酸或 111 个核苷酸重复的 A2 谱系病毒成为最常检测到的基因型。过去,针对新出现的谱系提出了不同的名称,这表明需要一个一致的命名约定。在这里,提出了新遗传谱系的命名标准,以有助于朝着系统的 HMPV 分类迈进。
人偏肺病毒(HMPV)是人类呼吸道感染的主要病原体之一。监测病毒进化可以帮助开发新的抗病毒治疗方法或疫苗设计。在这里,我们研究了 2005 年至 2021 年期间的 HMPV 进化情况,研究对象为从因 RI 住院的个体和因 RI 就诊的普通科医生处采集的样本。系统发生分析表明,HMPV 继续分为先前描述的四个亚谱系(A1、A2、B1 和 B2)。然而,亚谱系 A1 自 2006 年后不再被检测到,而其他亚谱系继续进化。在因 RI 住院和就诊的患者的样本中,优势(亚)谱系没有观察到差异。在两个人群中,附着蛋白基因中带有 180 个核苷酸或 111 个核苷酸重复的 A2 谱系病毒成为最常检测到的基因型。这些数据用于提出新遗传谱系的命名标准,以有助于朝着系统的 HMPV 分类迈进。